The extra time the US Food and Drug Administration took to produce guidance on live remote video plant tours reflects the agency’s enthusiasm for them, not a reluctance to supplement inspections with them during the pandemic, agency officials told the Pink Sheet.
The FDA produced a blizzard of COVID-19-related guidance documents in the spring and summer of 2020, including some that were...







